scispace - formally typeset
M

Michio Itabashi

Researcher at Memorial Hospital of South Bend

Publications -  134
Citations -  3541

Michio Itabashi is an academic researcher from Memorial Hospital of South Bend. The author has contributed to research in topics: Colorectal cancer & Cancer. The author has an hindex of 16, co-authored 114 publications receiving 2770 citations.

Papers
More filters
Journal ArticleDOI

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer

TL;DR: The English version of the JSCCR Guidelines 2016 is presented, which can be used as a tool for treating colorectal cancer in actual clinical practice settings and as a guide to obtaining informed consent from patients and choosing the method of treatment for each patient.
Journal ArticleDOI

Self-expanding stainless steel stent application in rectosigmoid stricture

TL;DR: Self-expanding stainless steel stents were used to dilate rectosigmoid strictures caused by nonresectable recurrent neoplasm and insertion and dilation in two patients were successful, and patients were able to maintain bowel activity and avoid palliative loop colostomy.
Journal ArticleDOI

Selection of Lymph Node–Positive Cases Based on Perirectal and Lateral Pelvic Lymph Nodes Using Magnetic Resonance Imaging: Study of the Japanese Society for Cancer of the Colon and Rectum

TL;DR: Identification of LN-positive cases on the basis of PRLN and LPLN sizes was superior at a short-axis 5 mm cutoff, and further investigation is needed to clarify whether it is superior to diagnosis based on morphology, such as shape, border, and signal intensity.
Journal ArticleDOI

Prognostic factors in patients undergoing complete resection of pulmonary metastases of colorectal cancer: a multi-institutional cumulative follow-up study

TL;DR: This retrospective analysis suggested that the indications for pulmonary resection of CRC metastases should be decided not only by the status of lung metastases, but also by pulmonary-related factors such as the T and N stage of the primary lesion, preoperative CEA level, and the DFI.